Biotech & Oncology: Orion Pharma reported first Phase 1/2 results for TEAD inhibitor ODM-212 in advanced solid tumors, with early responses and manageable safety. Cancer Care Tech: BioNTech and Bristol Myers Squibb shared interim ROSETTA Lung-02 Phase 2 data for pumitamig (PD-L1xVEGF-A) plus chemo in first-line NSCLC, showing strong activity across PD-L1 levels. Radiation Breakthrough: A study on tile-based radiation therapy (radioactive collagen tiles) in brain metastases claims major gains in local control and survival versus standard postoperative stereotactic radiation. Cybersecurity: Multiple US healthcare breaches exposed Social Security numbers and medical records, including a major New York City Health and Hospitals incident affecting millions. AI in Research: Google opened public registration for Co-Scientist’s hypothesis tool, following Nature publication of lab-validated results. Climate & Law: Switzerland raised the bar for climate claims, pushing companies to avoid greenwashing and “greenhushing.” Energy & Industry: Caudal Energy secured £4.3m for mid-flow tidal power testing, aiming for commercial deployment by 2028. Public Health Policy: Trump signed an order directing the CDC to align childhood vaccine scheduling with a prior HHS assessment calling for fewer shots. Workforce & Education: UW-Madison will debut free metals casting and CNC workforce hubs, while Malaysia’s UPSI plans a mountaineering school to cut hiking incidents. Environment & Health: Students in Sydney removed Agent Orange-related chemicals from a waterway, and researchers explored kimchi bacteria as a possible nanoplastic absorber.